UCB is a top pharmaceutical company based in Brussels, Belgium
UCB is a global biopharmaceutical company and is engaged in the discovery, development, manufacture and sale of health care products worldwide.
UCB aspires to be the patient-centric global biopharmaceutical leader transforming the lives of people living with severe diseases.
Report: Partnering Deals and Alliances with UCB
UCB is a top pharmaceutical company based in Brussels, Belgium.
The company was founded in 1928.
UCB is a global biopharmaceutical company and is engaged in the discovery, development, manufacture and sale of health care products worldwide.
The company aspires to be the patient-centric global biopharmaceutical leader transforming the lives of people living with severe diseases.
The company’s strategy involves focusing on severe diseases in two therapeutic areas:
- Immunology
UCB also has a selective presence in primary care.
UCB has an active licensing venture investment and acquisition group charged with analysing and managing all incoming opportunities. UCB has a long history of partnering, building numerous collaborative partnerships more
UCB announced over 94 partnering / licensing deals since 2005, with over 16 deals in 2006 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in central nervous system, Immunology, cardiovascular, cancer, followed by infectives, genitourinary and metabolic diseases more
UCB has also announced 2 M&A deals since 2005 more
Examples of recent partnering and licensing deals announced by UCB can be viewed in Current Partnering's Partnering Agreements with UCB 2005-2013 activity review article.
Examples of recent M&A deals announced by UCB can be viewed in Current Partnering's Partnering Agreements with UCB 2005-2013 activity review article.
Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with UCB
Available reports from Current Partnering
Report: Partnering Deals and Alliances with UCB
Report: Partnering Deals and Alliances with Big Pharma
Available resources for deal coverage for UCB
Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more
Read: more on UCB company profile, recent partnering, M&A and financing news and articles
Related
Report: Practical Guide to Finding Partners
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now
Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk
